Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Donn who wrote (7617)	5/1/1998 8:36:00 PM
From: AlienTech	Read Replies (1) \| Respond to of 23519

>>Now we just have to see if Muse is working for a good percentage of them. thanks for the updates<< MUSE has an average of 70% success rate. But that does not mean 70% of them will stick to it. I would expect a 50% drop off from this due to problems with the partner not intresting enough. So that still leaves around 25% of the ones whos tried it left. So lets hope a lot of people try it out. Which is why the new script data for next week will be telling. If there is a serious drop off then I would think its better to wait for MUSE2 and the other stuff to come out before buying this stock. Although shorting here like some is extremely bad form, You short at the top, not after the price has already declined 75%. But hey every dumb short helps, as shown by KTEL and DELL..